Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

06/23/08 With an inoperable brain tumor, Bob Tisch wound up at Duke        

06/23/08 Stereotactic Radiosurgery Can Extend Survival in Small Recurrent Glioblastomas        

06/23/08 Lovastatin enhances gefitinib activity in glioblastoma cells irrespective of EGFRvIII and PTEN status.        

06/23/08 Use of nanoparticles for cerebral cancer.        

06/23/08 In vitro and in vivo radiosensitization induced by the DNA methylating agent temozolomide.        

06/21/08 Musella Foundation Inkjet Recycling Fundraiser to end soon.        

06/20/08 ANNUAL NEUROSURGERY CHARITY SOFTBALL TOURNAMENT        

06/17/08 Improvement, clinical course, and quality of life after palliative radiotherapy for recurrent glioblastoma.        

06/17/08 Radiochemotherapy with temozolomide as re-irradiation using high precision fractionated stereotactic radiotherapy (FSRT) in patients with recurrent gliomas.        

06/17/08 Concurrent radiotherapy with temozolomide followed by adjuvant temozolomide and cis-retinoic acid in children with diffuse intrinsic pontine glioma        

06/17/08 Protox granted orphan status in Europe for brain cancer treatment        

06/17/08 Oncolytic Viruses Found to Stimulate Tumor Blood-Vessel Growth        

06/17/08 Second-line chemotherapy with fotemustine in temozolomide-pretreated patients with relapsing glioblastoma: a single institution experience.        

06/16/08 ASCO brain tumor review        

06/15/08 First - Do Not Give Up!        

06/13/08 UnlockingBrainTumors.org Seeks Participants and Sponsors for First Annual Charity Golf Event in Chicago Area, 8/18/08, to Benefit Pediatric Brain Tumor Research.        

06/11/08 7/17/08 Seattle: Lecture: Advanced Brain Tumors: Treatment Options        

06/09/08 What is the risk of intracranial bleeding during anti-VEGF therapy?        

06/09/08 External beam irradiation and the combination of cisplatin and carmustine followed by carmustine alone for the treatment of high-grade glioma: a phase 2 Southwest Oncology Group trial.        

---

Displaying Stories 3501 to 3520 of 7673
Previous 20           Next 20